<?xml version='1.0' encoding='utf-8'?>
<document id="24791374"><sentence text="Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine: a case of severe drug interaction."><entity charOffset="0-11" id="DDI-PubMed.24791374.s1.e0" text="Propafenone" /><entity charOffset="88-99" id="DDI-PubMed.24791374.s1.e1" text="mirtazapine" /><pair ddi="false" e1="DDI-PubMed.24791374.s1.e0" e2="DDI-PubMed.24791374.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24791374.s1.e0" e2="DDI-PubMed.24791374.s1.e1" /></sentence><sentence text="We describe a rare case of severe drug-drug interaction between propafenone and mirtazapine leading to propafenone toxicity"><entity charOffset="64-75" id="DDI-PubMed.24791374.s2.e0" text="propafenone" /><entity charOffset="80-91" id="DDI-PubMed.24791374.s2.e1" text="mirtazapine" /><entity charOffset="103-114" id="DDI-PubMed.24791374.s2.e2" text="propafenone" /><pair ddi="false" e1="DDI-PubMed.24791374.s2.e0" e2="DDI-PubMed.24791374.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24791374.s2.e0" e2="DDI-PubMed.24791374.s2.e1" /><pair ddi="false" e1="DDI-PubMed.24791374.s2.e0" e2="DDI-PubMed.24791374.s2.e2" /><pair ddi="false" e1="DDI-PubMed.24791374.s2.e1" e2="DDI-PubMed.24791374.s2.e1" /><pair ddi="false" e1="DDI-PubMed.24791374.s2.e1" e2="DDI-PubMed.24791374.s2.e2" /></sentence><sentence text=" A 69-year-old Caucasian male taking propafenone for atrial fibrillation was prescribed mirtazapine for insomnia"><entity charOffset="37-48" id="DDI-PubMed.24791374.s3.e0" text="propafenone" /><entity charOffset="88-99" id="DDI-PubMed.24791374.s3.e1" text="mirtazapine" /><pair ddi="false" e1="DDI-PubMed.24791374.s3.e0" e2="DDI-PubMed.24791374.s3.e0" /><pair ddi="false" e1="DDI-PubMed.24791374.s3.e0" e2="DDI-PubMed.24791374.s3.e1" /></sentence><sentence text=" Subsequent to the first dose of mirtazapine the patient experienced seizures, bradycardia and prolonged QRS as well as QTc intervals on EKG"><entity charOffset="33-44" id="DDI-PubMed.24791374.s4.e0" text="mirtazapine" /></sentence><sentence text=" The patient was admitted to the ICU and recovered after supportive management" /><sentence text=" Propafenone is an established class IC antiarrhythmic drug commonly used in the treatment of atrial fibrillation"><entity charOffset="1-12" id="DDI-PubMed.24791374.s6.e0" text="Propafenone" /></sentence><sentence text=" It is metabolized through the CYP4502D6 pathway" /><sentence text=" Five to 10 percent of Caucasians are poor metabolizers" /><sentence text=" Mirtazapine is a commonly prescribed antidepressant drug, which is also metabolized through and may modulate the CYP4502D6 pathway leading to altered metabolism of propafenone and possible adverse effects"><entity charOffset="1-12" id="DDI-PubMed.24791374.s9.e0" text="Mirtazapine" /><entity charOffset="165-176" id="DDI-PubMed.24791374.s9.e1" text="propafenone" /><pair ddi="false" e1="DDI-PubMed.24791374.s9.e0" e2="DDI-PubMed.24791374.s9.e0" /><pair ddi="false" e1="DDI-PubMed.24791374.s9.e0" e2="DDI-PubMed.24791374.s9.e1" /></sentence><sentence text=" In this case, toxicity was reversed once the offending drugs were discontinued" /><sentence text=" An extensive review of the literature revealed this to be the first described case of drug interaction between propafenone and mirtazapine"><entity charOffset="112-123" id="DDI-PubMed.24791374.s11.e0" text="propafenone" /><entity charOffset="128-139" id="DDI-PubMed.24791374.s11.e1" text="mirtazapine" /><pair ddi="false" e1="DDI-PubMed.24791374.s11.e0" e2="DDI-PubMed.24791374.s11.e0" /><pair ddi="false" e1="DDI-PubMed.24791374.s11.e0" e2="DDI-PubMed.24791374.s11.e1" /></sentence><sentence text="" /></document>